Tag Archives: GlaxoKlineSmith

Private health care: Placing children at risk to increase profit

You have to wonder how executives at GlaxoSmithKline sleep at night?

Yesterday the British drug manufacturer agreed to a civil settlement with the U.S. Government in which they will pay $3 billion in fines — the largest health care fraud settlement in that country’s history.

GSK admitted to misbranding antidepressants and marketing them for uses not approved by the U.S. Food and Drug Administration. That included marketing the antidepressant drugs to children despite warnings of an increased risk of suicide for children under 18.

Continue reading